Concepcion Ravelo Diaz-Arrastia, M.D.
Gynecologic Oncology Physician · Houston, TX
Concepcion Ravelo Diaz-Arrastia, M.D. is a gynecologic oncology physician with a practice address in Houston, Texas, and NPI 1104986553, issued on Dec 8, 2006. Check the license (Texas J1651, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Concepcion Ravelo Diaz-Arrastia
- Credential
- M.D.
- Primary taxonomy
- Gynecologic Oncology Physician 207VX0201X
- License number
- J1651 TX
Self-reported in NPPES; status is on the state search - Practice location
- 1213 Hermann Dr Ste 675, Houston, TX 77004
- Phone
- (713) 756-8555
- Enumerated
- Dec 8, 2006
- Record last updated
- Aug 8, 2018 (not updated in 8 years: call before relying on the address or phone)
- Fax
- (713) 756-8305
- Medicaid ID
- 124926003 TX
- Medicare enrollment
- Enrolled (PECOS I20090804000174); may accept Medicare assignment
- Entity
- Type 1 · individual
8 nearest gynecologic oncology physician records → All 149 in Texas → Look up another NPI →
Also registered at 1213 Hermann Dr Ste 675
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Sheila BlancoSurgical Physician Assistant1699387845
Verify Concepcion Ravelo Diaz-Arrastia in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license J1651Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
57% more Medicare Part D claims than the average gynecologic oncology physician in 2024
307 Medicare Part D claims for 90 beneficiaries, against an average of 195 among the 1,475 providers of this specialty who prescribed in Part D. Brand-name drugs were 15% of claims. 27 claims were for opioids.
Most prescribed
- Estradiol22 claims
- Tramadol Hcl22 claims
- Anastrozole19 claims
- Estradiol (Twice Weekly)17 claims
- Clobetasol Propionate15 claims
- Eliquis15 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $229.70
6 payments; by number, the most common kind was food and beverage; the largest payer was Ethicon US, LLC. The 1,199 providers of this specialty with any payment received $6,387.20 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Concepcion Ravelo Diaz-Arrastia among 149 gynecologic oncology physician records in Texas
Concepcion Ravelo Diaz-Arrastia, M.D. is one of 149 gynecologic oncology physician records with a practice address in Texas. 89% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 8% of them.
- NPI issued2006 · 8% of these records are older, 52% newer
- In a Medicare fileYes · 89% of these records are
- In the CMS Doctors and Clinicians fileYes · 80% of these records are
- Graduated1987 · median 2006 among the 119 with a school on file
- Record last updated2018 · 48% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207VX0201X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Gynecologic Oncology Physician providers in Texas
There are 149 gynecologic oncology physician records in Texas.
All 149 in Texas → Every provider in Houston → Gynecologic Oncology Physician nationwide →
The 8 gynecologic oncology physician records with the nearest ZIP codes
- Alpa Nick, MDHouston, TX 770241265589139
- Barry Siller, M.D.Houston, TX 770241427034925
- David Boruta, MDHouston, TX 770301699729236
- Robert Coleman, M.D.Houston, TX 770301669570685
- Geri-Lynn Fromm, M.D.Houston, TX 770301851376594
- David Gershenson, M.D.Houston, TX 770301477651099
- Aparna Kamat, M.D.Houston, TX 770301992732887
- Elizabeth Keeler, M.D.Houston, TX 770301144321209
Common questions
What is Concepcion Ravelo Diaz-Arrastia, M.D.'s NPI number?
Concepcion Ravelo Diaz-Arrastia, M.D.'s National Provider Identifier (NPI) is 1104986553, issued on Dec 8, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Concepcion Ravelo Diaz-Arrastia, M.D. located?
The NPPES record lists a practice address at 1213 Hermann Dr Ste 675, Houston, TX, 77004. Phone: (713) 756-8555. Providers update this record themselves, so call before visiting.
How can I verify Concepcion Ravelo Diaz-Arrastia, M.D.'s license?
NPPES lists Texas license number J1651, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Concepcion Ravelo Diaz-Arrastia, M.D. prescribe under Medicare Part D?
In 2024, Concepcion Ravelo Diaz-Arrastia, M.D. had 307 Medicare Part D claims for 90 beneficiaries; the average among gynecologic oncology physician prescribers was 195. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.